| Manager | Title | Age | Since |
|---|---|---|---|
Ola Holmlund
CEO | Chief Executive Officer | 57 | 01/01/2018 |
Jan Holmbäck
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/01/2010 |
Charlotta Ekman
DFI | Director of Finance/CFO | 45 | 01/10/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Ola Flink
CHM | Chairman | 82 | 01/01/2017 |
| Chairman | 46 | 01/01/2020 | |
Gunilla Lundmark
BRD | Director/Board Member | 63 | 01/06/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -98.73% | - | - | 92.63K | |
| -1.06% | +0.65% | +77.42% | +122.82% | 1,100B | |
| +0.04% | +0.75% | +53.10% | +64.29% | 658B | |
| +0.48% | +2.65% | +28.06% | +81.19% | 470B | |
| -0.83% | +1.09% | +43.29% | +43.31% | 372B | |
| -0.57% | +0.58% | +26.24% | +41.34% | 304B | |
| -1.28% | +2.32% | +3.86% | +14.12% | 264B | |
| -0.36% | +3.99% | +53.31% | +72.49% | 239B | |
| +0.08% | +3.07% | -12.05% | -52.26% | 213B | |
| +1.38% | +3.72% | +30.33% | +93.56% | 184B | |
| Average | -0.08% | +3.01% | +33.73% | +53.43% | 422.54B | |
| Weighted average by Cap. | -0.00% | +2.21% | +45.79% | +71.36% |
Employees
4
Sector
Pharmaceuticals
